THE FXYD FAMILY OF PROTEINS consists of seven members each containing a conserved FXYD motif (34) . Expression of the different family members appears to be tissue specific. For example, phospholemman (PLM) (FXYD1) has been identified in heart, skeletal muscle, and neuronal tissues, the ␥-subunit of Na ϩ -K ϩ -ATPase (FXYD2) and corticosteroid hormone-induced factor (FXYD4) are expressed in kidney, and FXYD7 is expressed in the brain (5, 10) . More recently, a PLM-like protein has been identified in shark rectal glands (22) .
Four members of this family (the ␥-subunit, PLM, corticosteroid hormone-induced factor, and FXYD7) have been shown to be associated with Na ϩ -K ϩ -ATPase (4 -6, 12) . Of particular interest is PLM, which was originally discovered as a major substrate of protein kinase A and protein kinase C in the plasma membrane of cardiac and skeletal muscle (17, 18, 28, 29, 35) . Although several recent publications have begun to characterize PLM, its biochemical and physiological role remains incompletely understood. In neuronal tissues, Feschenko and coworkers (12) demonstrated that PLM is associated with all three ␣-subunit isoforms of the Na ϩ -K ϩ -ATPase, and the association appears to activate Na ϩ -K ϩ -ATPase activity without changing the Na ϩ affinity of the enzyme. By contrast, Crambert and coworkers (11) showed that PLM alters both the Na ϩ and K ϩ affinity of Na ϩ -K ϩ -ATPase when they were coexpressed in Xenopus oocytes. Furthermore, they demonstrated that, in skeletal muscle, PLM associates predominantly with the ␣ 1 -and not the ␣ 2 -isoform. In myocardium, PLM also appears to be selectively associated with the ␣ 1 -isoform, and ischemia increases phosphorylation of PLM and results in increased Na ϩ -K ϩ -ATPase enzymatic activity (14) . In addition, ␣ 1 -specific activation by protein kinase A cascade appears to be mediated through phosphorylation of PLM (31) . In shark rectal gland, the PLM-like protein has been reported to decrease Na ϩ affinity and enzymatic activity, and phosphorylation of the protein increased Na ϩ -K ϩ -ATPase activity (21, 22) . Together, these data suggest tissue-specific expression and perhaps isoform-specific regulation of Na ϩ -K ϩ -ATPase by PLM.
In skeletal muscle, Na ϩ -K ϩ -ATPase plays a critical role in the maintenance of Na ϩ -K ϩ homeostasis, which in turn modulates muscle function (7, 9, 23, 26) . In previous studies, our laboratory demonstrated that expression of the ␣-and ␤-subunit isoforms is differentially altered during aging and that exercise training was able to reverse some, but not all, of the age-related changes (25, 33) . If PLM is indeed an accessory protein of the Na ϩ -K ϩ -ATPase (12), it may ultimately play a substantial role in modulating skeletal muscle physiology. Therefore, the first objective of the present study was to further characterize the PLM in skeletal muscle in young and middleaged rats. The second objective was to test, in middle-aged and aged rats, the hypothesis that, as an accessory protein of the Na ϩ -K ϩ -ATPase, expression of PLM and its association with Na ϩ -K ϩ -ATPase is altered during aging and after exercise training. Parts of this paper were published previously in abstract form (30) .
MATERIALS AND METHODS
Animals used. Male Fischer 344x Brown Norway rats (Harlan, Indianapolis, IN) were housed in a 12:12-h light-dark cycle and given standard rat chow and water ad libitum. To specifically identify alterations that are more likely to be the result of aging, without complications from normal maturation, we chose to examine the effects of aging on expression of PLM in 16-mo-old middle-aged rats and 29-mo-old senescent rats in our study. This is because changes that are observed between these age groups are more likely to reflect aging-related alterations rather than changes that may occur as a result of normal development and maturation. However, in experiments where aging is not the main focus, we choose to examine preparations from 6-and 16-mo-old rats to illustrate what typically would be detected in the skeletal muscle of young and middle-aged rats, age groups that investigators are more likely to study. All animal-use protocols were approved by the institutional animal care committees at University of Colorado and The Pennsylvania State University, College of Medicine.
Exercise training of rats. The protocol for the training of rats was published previously (15, 25) . Briefly, the 26-mo-old rats were randomly assigned to either the sedentary or the exercise-trained group. Animals in the trained group underwent 13-14 wk of running on a motorized treadmill. During the first 2 wk, running duration and speed were progressively increased. From the start of week 3 until the death date, the final training protocol consisted of running 5 days/wk up a 10% grade at 14 m/min for 5 min and 17 m/min for 40 min for a total of 45 min. About 24 h (Ϯ4 h) after the last bout of exercise training, the rats were anesthetized with intraperitoneal pentobarbital sodium (35 mg/kg) at least 15 min after heparin injection (250 units). Skeletal muscles were dissected after hearts were removed. The red (GR) and white gastrocnemius (GW) muscles were dissected and separated for use in some experiments, whereas in other experiments these muscles were not separated, and the whole gastrocnemius muscle is referred to as mixed gastrocnemius muscle. The three experimental groups were 16-mo-old middle-aged sedentary (Ms); 29-mo-old senescent sedentary (Ss); and 29-mo-old senescent exercise trained (St). Increased citrate synthase activity indicated that the muscles underwent significant adaptation to exercise (25) .
Preparation of tissue homogenates. Total tissue homogenates were prepared as described previously (25) . Briefly, skeletal muscles (ϳ200 -300 mg) were pulverized and homogenized with a Polytron (Brinkmann Instruments, Westbury, NY) at a speed of 6.5 (11.0 full scale) for three 20-s periods at 4°C in a buffer containing 10 mM Tris ⅐ HCl (pH 7.5), 1 mM EDTA, and protease inhibitors (in M: 500 phenylmethylsulfonyl fluoride, 1 leupeptin, 1 pepstatin, and 10 E-64). Protein concentrations were determined by the Bio-Rad protein assay (Bio-Rad, Melville, NY).
Preparation of partially purified membrane. The mixed gastrocnemius muscles from the Ms, Ss, and St rats and from 6-mo-old rats used in the immunofluorescence study were homogenized in ice-cold buffer (200 mg/2 ml) containing (in mM) 250 sucrose, 30 imidazole, and 1 EDTA (pH 7.3) using a Potter-type homogenizer with a motor-driven Teflon pestle. The homogenates were then centrifuged at 3,000 g for 15 min at 4°C, and the supernatants were collected and centrifuged at 140,000 g at 4°C for 1 h. The pellets were then resuspended in 100 -200 l of buffer containing (in mM) 140 NaCl, 25 Imidazole, and 1 EDTA (pH 7.3). Protein concentrations were then determined as described above. These preparations were used in immunoprecipitation experiments.
Enzyme activity assay preparation. Tissue homogenates were prepared as above and frozen at Ϫ80°C and used within a week. The method for Na ϩ -K ϩ -ATPase enzyme activity assay is similar to that described previously by Feschenko et al. (12) with slight modifications as described previously (25) . Briefly, the homogenates were diluted with the homogenizing buffer to 150 g/40 l and subjected to rapid "freeze and thaw" 10 times. Total ATPase activity was assayed in a buffer containing (in mM) 100 NaCl, 15 KCl, 5 MgCl2, 5 NaN 3, 50 Tris ⅐ HCl (pH 7.8 at room temperature), and 1 EGTA in 2 mM Tris (pH 7.8, room temperature). After a 10-min preincubation at 37°C, the reaction was started by adding ATP to a final concentration of 5 mM with a trace amount of [␥-32 P]ATP (ICN, Irvine, CA). Nonspecific ATPase activity was assayed in the presence of 2 mM ouabain. In assays where anti-PLM antibody was added, it was first cleared of contaminants by using a Micron YM-10 centrifugal filter (Millipore, Bedford, MA). Anti-PLM or control IgG (Southern Biotech, Birmingham, AL) (ϳ1.5 g) was incubated with homogenates in assay buffer for 4 h at 4°C before the ATP was added to start the reaction. After a 25-min reaction, 500 l of the quenching solution (1 NH 2SO4 and 0.50% ammonium molybdate) were added, and samples were placed on ice. Isobutanol (1 ml) was added, vigorously vortexed, and centrifuged to separate the organic phase from the aqueous phase. The upper organic phase (500 l) was added to scintillation fluid and counted with a scintillation counter.
Western blot analysis. PLM and Na ϩ -K ϩ -ATPase subunits were separated by 4 -20% SDS-PAGE and transferred to polyvinylidene difluoride membrane as described previously (25, 33) . The antibody to the COOH-terminus of PLM (57-70) was purified on a peptide affinity column and represents antibodies reacting specifically with nonphosphorylated PLM as previously described (19) . The antibody to the ␣ 2-isoform (McB2) was kindly provided by K. Sweadner (Harvard University). The antibody to the ␣1-isoform (␣6f) was purchased from Developmental Studies Hybridoma Bank (University of Iowa). Blots probed for PLM were blocked with 5% dry milk in TBS-Tween 20 (Blotto) overnight at 4°C then probed with the anti-PLM antibody (1:1,000) for 2 h. The blots probed for ␣1-isoform were blocked in Blotto and probed with anti-␣1-antibody (1:250) overnight at 4°C. Bound monoclonal antibodies were detected by horseradish peroxidase-linked goat anti-mouse antibody (Rockland Immunochemicals, Gilbertsville, PA), and bound polyclonal antibodies were detected by horseradish peroxidase-linked goat anti-rabbit IgG (Sigma, St. Louis, MO). The blots probed for ␣2-isoform were blocked with TBS-Tween 20 for 1 h, then probed with anti-␣2-antibody (1:150) overnight at 4°C. Bound ␣2-antibodies were detected by incubating the blots with an unconjugated chicken anti-mouse IgG antibody to amplify the signals (ICN, Costa Mesa, CA) followed by the horseradish peroxidase-linked donkey anti-chicken IgG (ICN, Irvine, CA). Detection was performed with a chemiluminescent method (SuperSignal West Pico or West Femto, Pierce, Rockford, IL), and imaging analysis was performed with a Fujifilm Luminescent Imager (Fuji Photo Film, Japan) using the Image Gauge analysis software. Data are presented in arbitrary chemiluminescent units. All images analyzed were within the linear range of detection.
Immunoprecipitation. The protocol for immunoprecipitation was basically identical to that described by Feschenko et al. (12) . Partially purified membrane preparations (125 g/50 l for 6-mo-old rat samples and 100 g/50 l for all other samples) were incubated with C12E8 (6 mg/ml) at room temperature for 20 min with intermittent mixing. The mixtures were diluted 1:1 with buffer B [in mM: 140 NaCl, 25 Imidazole, 1 EDTA (pH 7.
3)] and centrifuged at 20,000 g at 4°C for 30 min. The supernatant was precleared of nonspecific binding with 15 l of Gammabind G-sepharose (Amersham Biosciences, Piscotaway, NJ) for 1 h at room temperature with gentle agitation. The supernatants were then incubated with anti-PLM antibody (0.5 l/tube) at 4°C overnight. The complexes were immunoprecipitated by incubating with 15 l of Gammabind G-sepharose for 1 h at room temperature. The samples were centrifuged followed by three washes with buffer B containing 0.05% C12E8 (buffer C). For the Ms, Ss, and St samples, a final fourth wash in buffer C without NaCl was performed. Samples were incubated with 40 l of electrophoresis sample buffer at room temperature for 20 min and centrifuged, and the supernatant was saved. Another 30 l of sample buffer were added to the pellets, and the resuspended mixtures were centrifuged again. Supernatants were combined, then additional ␤-mercaptoethanol (10%) was added to ensure complete dissociation of the IgG chains, and the samples were incubated at 65°C for 10 min and stored frozen at Ϫ20°C until used.
Immunofluorescent labeling of skeletal muscle. Six-month-old rats were anesthetized with intraperitoneal pentobarbital sodium (35 mg/ kg) at least 15 min after heparin injection (1,000 IU/kg). Skeletal muscles were dissected and cryoprotected in isopentane, and 8-m cryostat sections from GR and GW were collected on the same slides to be processed together. The sections were fixed in a 1:1 acetone and methanol solution, incubated in 0.5% NaBH 4 to decrease autofluorescence, and permeabilized in PBS with 0.5% Triton X-100 for 10 min at room temperature. Labeling was performed using monoclonal anti-␣ 2 (McB2; 1:10) and polyclonal anti-PLM (1:50) antibodies. The anti-PLM antibody first was cleared of cross-reacting antibodies by immunoabsorption using a strip that was blotted with the skeletal muscle proteins except PLM. Alexa Fluor 488 goat anti-rabbit IgG and Alexa Fluor 546 goat anti-mouse IgG (1:200) (Molecular Probes, Eugene, OR) were used as secondary antibodies. Microscopy was performed using a Nikon (Melville, NY) fluorescence microscope, and images were processed using Photoshop software (Adobe).
Statistics. Results are expressed as means Ϯ SD. One-way ANOVA was used to compare group means, and a Duncan test was used in post hoc analysis. One set of data (Fig. 1) was analyzed by repeated-measures ANOVA. Data were examined at P Ͻ 0.05 and P Ͻ 0.10 to indicate statistical significance and trends, respectively.
RESULTS

Expression of PLM in different muscle types.
Although several studies have demonstrated the presence of PLM in skeletal muscle (11, 36, 37) , it was unclear whether expression of PLM differs among muscle and/or fiber types. Therefore, GR, GW, and extensor digitorum longus (EDL), representing fast oxidative glycolytic/slow oxidative muscle, fast glycolytic, and fast oxidative glycolytic/fast glycolytic, respectively, from adult rats (16 mo old) were examined. Figure 1 shows that levels of expression of PLM were higher in EDL compared with GW; there was no significant difference between GR and GW (GR ϭ 1.00 Ϯ 0.26; GW ϭ 0.89 Ϯ 0.06, EDL ϭ 1.18 Ϯ 0.12 in arbitrary units).
Immunofluorescence labeling of PLM. To determine the cellular distribution of PLM in the skeletal muscle fibers, immunofluorescent labeling of PLM was performed in GR and GW. As shown in Fig. 2 , the ␣ 2 -isoform of Na ϩ -K ϩ -ATPase, a membrane protein, was fairly evenly distributed on the sarcolemmal membrane across fibers in both GR and GW. b Significantly different from GW (P Ͻ 0.05). Some of the fibers showed intracellular labeling; however, it is unclear whether this was a specific signal for ␣ 2 . In both skeletal muscles, PLM also can be found prominently labeled on the sarcolemmal membrane.
Association of PLM with Na ϩ -K ϩ -ATPase. Coimmunoprecipitation experiments were performed to determine whether PLM preferentially associates with the ␣ 1 -and/or ␣ 2 -isoform of the Na ϩ -K ϩ -ATPase, the two ␣-subunit isoform proteins known to be expressed in rat skeletal muscle (2, 3, 33) . In mixed gastrocnemius muscle, PLM coimmunoprecipitated with both the ␣ 1 -as well as the ␣ 2 -subunit isoforms (Fig. 3) .
Effects of PLM on Na ϩ -K ϩ -ATPase enzymatic activity in skeletal muscle. A study by Feschenko and coworkers (12) demonstrated that, in the central nervous system, PLM and Na ϩ -K ϩ -ATPase not only are physically associated but are also functionally associated. Figure 4 shows that incubation of tissue homogenates from mixed gastrocnemius with the anti-PLM antibody significantly decreases Na ϩ -K ϩ -ATPase enzymatic activity by Ͼ50% compared with the samples with no treatment or with control IgG. These data suggest that, in skeletal tissue, PLM modulates, directly or indirectly, the activity of the Na ϩ -K ϩ -ATPase.
Effects of aging and exercise training on PLM expression.
Our previous studies have shown that the levels of expression of the Na ϩ -K ϩ -ATPase subunit isoforms are significantly altered in aged skeletal muscle, and endurance exercise training reverses some of these alterations. Therefore, in this study, we examined the expression of PLM with aging and after exercise training. Between adult sedentary and aged sedentary rats, there appears to be no significant changes in the levels of PLM in GR, GW, and EDL (Fig. 5) . Exercise training, however, greatly increased levels of PLM in all three muscle groups: EDL by 154%, GR by 150%, and GW by 152%.
Effects of aging and exercise training on association of PLM and Na
ϩ -K ϩ -ATPase. The levels of ␣ 1 coimmunoprecipitated with PLM increased significantly in 29-mo-old rats compared with 16-mo-old rats, and there was a trend for exercise training to partially reverse that increase (P ϭ 0.070) (Ms ϭ 1.00 Ϯ 0.21; Ss ϭ 3.25 Ϯ 0.49; St ϭ 2.22 Ϯ 0.60) (Fig. 6 ). By contrast, there was no change in the levels of ␣ 2 coimmunoprecipitated with PLM in the 16-and 29-mo-old rats; however, there was a trend for exercise training to increase the levels of PLM-associated ␣ 2 in 29-mo-old sedentary rats (P ϭ 0.062) (Ms ϭ 1.0 Ϯ 0.05; Ss ϭ 1.10 Ϯ 0.32; St ϭ 1.61 Ϯ 0.20).
DISCUSSION
Previous reports have demonstrated that skeletal muscle expresses some of the highest levels of PLM among all tissues examined (8, 28) , although very little is known about this protein within skeletal muscle. This study is the first detailed characterization of PLM as an accessory protein of Na ϩ -K ϩ -ATPase in skeletal muscle. The important findings are that, in skeletal muscle 1) levels of expression of PLM appear to be muscle-type dependent; 2) PLM appears to be required for Na ϩ -K ϩ -ATPase to express its full activity in skeletal muscle; 3) exercise training, but not aging, alters expression of PLM; 4) PLM is associated with the ␣ 1 -as well as the ␣ 2 -isoform of Na ϩ -K ϩ -ATPase; and 5) aging modulates the levels of PLMassociated ␣ 1 -isoform, and exercise training has a tendency to modulate the levels of PLM-associated ␣ 1 -and ␣ 2 -isoform.
The present results show that, in the adult rat, among the three tissues that we examined, EDL expresses higher levels of PLM and GW expresses lower levels, with GR expressing an intermediate level that is not statistically different from EDL or GW. In rat skeletal muscle, GR consists mainly of fastoxidative glycolytic (ϳ60%) and slow-oxidative (ϳ30%) fibers, whereas GW consists mainly of fast glycolytic (ϳ80%) and fast-oxidative glycolytic (ϳ15%). EDL, on the other hand, consists mainly of fast-oxidative glycolytic (ϳ40%) and fast Fig. 3 . Association of the ␣-subunit isoforms with PLM. Coimmunoprecipitation of PLM and the ␣-subunit isoforms was performed using partially purified membrane preparation from mixed GR and GW (125 g) of 6-mo-old rat. Anti-PLM antibody was used for immunoprecipitation, and the blots were probed with ␣1, ␣2, and PLM antibodies. A control with anti-PLM antibody but no membrane preparation (IP Ab) was included to demonstrate a lack of IgG signal at the 100-kDa molecular size range in the coimmunoprecipitation. Another control with membrane preparation but no anti-PLM antibody was also included (No IP Ab). The brain sample because of its abundance in ␣1, ␣2, and PLM was used as positive and negative controls. MB, skeletal muscle membrane preparation used for the immunoprecipitation experiments that shows the presence of ␣1, ␣2, and PLM in the sample before immunoprecipitation; IP, immunoprecipitation; IB, immunoblotting; SK, skeletal muscle. Fig. 4 . Effect of PLM antibody on Na ϩ -K ϩ -ATPase activity. Mixed GR and GW tissue homogenates (n ϭ 3; 150 g) from a 6-mo-old rat were incubated with 1.5 g of anti-PLM antibody (anti-PLM), rabbit IgG, or no treatment (control) for 4 h. Enzyme activity was assayed as described in MATERIALS AND METHODS.
a Significantly different from control samples (P Ͻ 0.05).
b Significantly different from samples treated with rabbit IgG (P Ͻ 0.05).
glycolytic (ϳ50%) (1). Thus our data do not suggest a correlation between muscle fiber type and apparent expression of PLM, but rather expression appears to be dependent on muscle type. The reason underlying this muscle type-dependent difference is not immediately clear. It is well known that postural and locomotive muscles, because of functional differences, may express different levels of proteins. Because both gastrocnemius and EDL are locomotive muscles, it is unlikely that differences in mechanical activation underlie the differences in PLM expression.
Our data show, for the first time using immunofluorescence, a predominance of sarcolemmal distribution of PLM in skeletal muscles. This result is consistent with a large body of evidence, based on membrane fractionation studies, showing that PLM is mainly a sarcolemmal protein (28, 29, 36) . However, we cannot exclude the possibility of minor distribution of PLM in other cellular compartments. For example, in rat cardiac myo- b Significantly different from Ss samples (P Ͻ 0.05). Fig. 6 . Levels of ␣1 and ␣2 associated with PLM in skeletal muscle of Ms, Ss, and St rats. Partially purified membrane preparations (100 g; n ϭ 3) from mixed gastrocnemius were immunoprecipitated with anti-PLM antibody, and the blots were probed with ␣1 (shaded bar), ␣2 (solid bar), and PLM antibodies. A control with anti-PLM antibody but no membrane preparation (IP Ab) was included to demonstrate a lack of IgG signal in the coimmunoprecipitation. Another control with membrane preparation but no anti-PLM antibody was also included (No IP Ab). Data were normalized to the levels in Ms rats. a Significantly different from Ms samples (P Ͻ 0.05).
bЈ Trend to be different from Ss.
cytes, it has been demonstrated that PLM is distributed in the plasma membrane as well as T tubules (32) . Importantly, the even distribution of PLM staining among fibers suggests that there is very little fiber-type-specific expression of PLM in the skeletal muscles that we have examined (fiber-typing data not shown). Because serial sections were not used in the present study, we are unable to discern from the immunofluorescent images whether PLM and the ␣-subunit indeed colocalized on the sarcolemmal membrane. However, in a recent report, Silverman et al. (31) demonstrated, by merging immunofluorescent labeling techniques, the colocalization of PLM and ␣-subunit of Na ϩ -K ϩ -ATPase in ventricular myocytes. In our study, incubation of tissue homogenates with anti-PLM antibody decreased Na ϩ -K ϩ -ATPase enzyme activity. Although we do not know the maximal activity of the Na ϩ -K ϩ -ATPase in the homogenates, our data suggest that PLM is required for Na ϩ -K ϩ -ATPase to express its full activity in skeletal muscle. This is similar to the finding by Feschenko et al. (12) who showed that, in neuronal tissue, PLM appears to function as an activator of Na ϩ -K ϩ -ATPase activity. It is worth mentioning that in the present study exercise training increased PLM by almost 50% in all three skeletal muscle types examined. Yet, in our previous study (25) , only GR and GW showed elevated enzyme activity after exercise training. Collectively, the results seem to suggest that increased expression of PLM alone does not necessarily lead to elevated Na ϩ -K ϩ -ATPase enzyme activity. It is possible that these PLM may be associated with other cellular proteins that PLM is known to be associated with, such as the Na ϩ /Ca 2ϩ exchanger (24) . Presently, it is not understood how the antibody decreases enzymatic activity. Whether the antibody modifies phosphorylation and/or association of PLM with Na ϩ -K ϩ -ATPase should be the subject of further studies.
Previous results from our laboratory and others have demonstrated that expression of the Na ϩ -K ϩ -ATPase subunit isoforms in skeletal muscle is dynamically regulated under physiological and pathological conditions. More specifically, we have shown that, with age, the expression of both the ␣-and ␤-subunit isoforms undergoes tissue-and isoform-specific regulation (33). Endurance exercise training was able to reverse some, but not all, of the aging-related deficits (25) . Our present data show that the level of expression of PLM was not modified by advancing age but was significantly increased by exercise training in aged animals. To the best of our knowledge, we believe this is the first demonstration that the expression of PLM is modified by a physiological or pathological condition. The increased level of PLM may help to modulate the activity of Na ϩ -K ϩ -ATPase. In addition, the long-term vs. acute effects of exercise training on the expression of PLM have yet to be established.
Because multiple isoforms of Na ϩ -K ϩ -ATPase are typically expressed in a particular tissue, the question of whether PLM associates only with certain isoforms and, therefore, regulates Na ϩ -K ϩ -ATPase in an isoform-specific manner is an intriguing one. In the central nervous system, PLM appears to associate equally with the ␣ 1 -, ␣ 2 -, and ␣ 3 -subunit isoforms (12) , whereas in skeletal and cardiac muscle PLM reportedly was associated exclusively with the ␣ 1 -isoform (11, 14, 31) . By contrast, our coimmunoprecipitation data show the association of PLM with both the ␣ 1 -and ␣ 2 -isoforms. The reason underlying the apparent discrepancy between our results and the previously published data is not immediately clear. Because the report by Crambert et al. (11) did not specify the type of muscle used in their study, it cannot be determined whether muscle type could explain the discrepancy. However, association of PLM with an ␣-subunit isoform may be dictated by the relative distribution of the isoform in the sarcolemma and T tubule (13, 31) . For example, in guinea pig ventricular myocytes, it has been shown that ␣ 2 interacts very little with PLM because ␣ 2 is predominantly localized to T tubules and PLM is predominantly localized to peripheral sarcolemma (31) . Thus our data appear to suggest that, in skeletal muscle, PLM and the ␣ 1 -and ␣ 2 -isoforms are all localized in similar subcellular compartments. Our findings may be significant in that, in skeletal muscle, the ␣ 2 -isoform is the major Na ϩ -K ϩ -ATPase isoform being expressed (20, 27) . If PLM had associated minimally to this isoform, as reported by others, it would have suggested that PLM could only modulate a relatively small fraction of the Na ϩ -K ϩ -ATPase in skeletal muscle. The importance of PLM in regulating skeletal muscle Na ϩ -K ϩ -ATPase, if it indeed occurs, could thus be questioned. On the contrary, our result demonstrates that PLM has the potential to modulate a majority of the Na ϩ -K ϩ -ATPase in skeletal muscle, suggesting perhaps a more significant role of PLM in skeletal muscle physiology than previously envisioned.
It is worth noting that our coimmunoprecipitation data showed that, in skeletal muscle and brain tissues, the same amount of PLM appears to be associated with very different amounts of the ␣ 1 -and ␣ 2 -subunits (Fig. 3) . This suggests that there may be tissue-dependent differential association of PLM with the ␣-subunits due to either the different amounts of ␣-subunits being expressed in these tissues and/or different affinity of association. The data further suggest that not all PLM is associated with the ␣-subunits, which is perhaps expected since PLM may serve other cellular functions (32, 35, 38) .
Although expression of PLM was unaltered by age, the levels of PLM-associated ␣ 1 -isoform increased with age and had a tendency to be partially reversed by exercise training. On the other hand, PLM-associated ␣ 2 -isoform did not change with age but had a tendency to increase after exercise training. This increase in PLM-associated ␣ 1 compared with PLMassociated ␣ 2 with age suggests that PLM may play a more important role in regulating ␣ 1 during aging. The changes in PLM-associated ␣-subunit isoforms appear to follow similar trends with the changes in overall expression of the ␣-subunit isoforms with age and after exercise training, as we have reported previously (25) . Specifically, we showed that ␣ 1 expression increases with age and that exercise training has marginal effect on its expression. There was a trend for decreased ␣ 2 levels with age, and exercise training significantly increased the levels.
A limitation in the design of the experiments is that the sample size in two of the experiments (Figs. 4 and 6 ) is small (n ϭ 3). The reason for the small sample size in those experiments is due to the limited amount of antibody that we had and the large amount of antibody that is required for performing the enzyme activity assay and immunoprecipitation. Because of the small sample size, our analysis may be prone to type II error. The fact that statistical significance was still found between some of the treatment groups would seem to suggest that, despite the potential pitfall, the analysis was able to discern at least the more substantial changes.
Functional significance of the modulation of Na ϩ -K ϩ -ATPase activity by PLM in skeletal muscle remains to be fully elucidated. However, a recent study by Jia et al. (16) demonstrated that, in the myocardium of PLM-deficient mice, there was a reduction in Na ϩ -K ϩ -ATPase activity, changes in Na ϩ -K ϩ -ATPase isoform expression, an increase in ejection fraction, and an increase in cardiac mass. Thus this appears to be the clearest demonstration yet of the important physiological role of PLM with respect to Na ϩ -K ϩ -ATPase at the cellular and functional levels.
In conclusion, PLM appears to be an integral part of Na ϩ -K ϩ -ATPase in skeletal muscle and has the potential to modulate the Na ϩ -K ϩ -ATPase in an isoform-specific and muscle type-dependent manner during aging and after exercise training.
